Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Sees Large Decline in Short Interest

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the target of a large decline in short interest during the month of February. As of February 28th, there was short interest totalling 1,300 shares, a decline of 35.0% from the February 13th total of 2,000 shares. Based on an average daily volume of 13,600 shares, the short-interest ratio is presently 0.1 days.

Analysts Set New Price Targets

Separately, The Goldman Sachs Group upgraded Carl Zeiss Meditec from a “sell” rating to a “buy” rating in a report on Tuesday.

Carl Zeiss Meditec Trading Up 7.4 %

Shares of Carl Zeiss Meditec stock traded up $4.82 on Friday, hitting $69.73. 3,001 shares of the company were exchanged, compared to its average volume of 8,289. The company has a 50-day moving average price of $57.86 and a 200 day moving average price of $61.21. Carl Zeiss Meditec has a 1-year low of $46.13 and a 1-year high of $133.15.

Carl Zeiss Meditec Announces Dividend

The business also recently announced an annual dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.6246 per share. This represents a dividend yield of 1%. The ex-dividend date of this dividend is Friday, March 28th. Carl Zeiss Meditec’s dividend payout ratio is currently 32.64%.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.